医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
13期
117-118
,共2页
心力衰竭%美托洛尔%参麦注射液
心力衰竭%美託洛爾%參麥註射液
심력쇠갈%미탁락이%삼맥주사액
Heart failure%Metoprolol%Shenmai Injection
目的就美托洛尔、参麦注射液联合在慢性心力衰竭治疗中的作用进行探析。方法择取我科室在近期内收治的77例慢性心力衰竭患者,将其中单一实施美托洛尔进行治疗的38例患者记为单一组,将增加实施参麦注射液治疗的39例患者记为联合组,比对两组患者治疗后的心功能改善情况及有效率。结果在疗效方面,联合组患者明显优于单一组(P<0.05);在左心室射血分数的改变情况上,单一组与联合组患者均有明显的改善,但组间比对,联合组的改善较佳(P<0.05)。结论采取美托洛尔、参麦注射液对慢性心力衰竭患者实施联合治疗后的效果是十分理想的,此法应在各医院开展实施。
目的就美託洛爾、參麥註射液聯閤在慢性心力衰竭治療中的作用進行探析。方法擇取我科室在近期內收治的77例慢性心力衰竭患者,將其中單一實施美託洛爾進行治療的38例患者記為單一組,將增加實施參麥註射液治療的39例患者記為聯閤組,比對兩組患者治療後的心功能改善情況及有效率。結果在療效方麵,聯閤組患者明顯優于單一組(P<0.05);在左心室射血分數的改變情況上,單一組與聯閤組患者均有明顯的改善,但組間比對,聯閤組的改善較佳(P<0.05)。結論採取美託洛爾、參麥註射液對慢性心力衰竭患者實施聯閤治療後的效果是十分理想的,此法應在各醫院開展實施。
목적취미탁락이、삼맥주사액연합재만성심력쇠갈치료중적작용진행탐석。방법택취아과실재근기내수치적77례만성심력쇠갈환자,장기중단일실시미탁락이진행치료적38례환자기위단일조,장증가실시삼맥주사액치료적39례환자기위연합조,비대량조환자치료후적심공능개선정황급유효솔。결과재료효방면,연합조환자명현우우단일조(P<0.05);재좌심실사혈분수적개변정황상,단일조여연합조환자균유명현적개선,단조간비대,연합조적개선교가(P<0.05)。결론채취미탁락이、삼맥주사액대만성심력쇠갈환자실시연합치료후적효과시십분이상적,차법응재각의원개전실시。
Objective Shenmai injection combined with metoprolol in patients with chronic heart failure ef ect analysis. Methods 77 cases of patients with chronic heart failure in our department were selected in the near future, the single effect of metoprolol for treatment of 38 patients were recorded as a single group, will increase the implementation of Shenmai injection in treatment of 39 patients were recorded as United Group, heart function than the patients in the two groups after treatment and improve ef iciency. Results In terms of ef icacy, patients in the combination group was obviously bet er than that of single group ( <0.05);the changes of left ventricular ejection fraction, improved significantly in the single group and the combined group of patients, but between group comparison, combined group improved bet er ( <0.05). Conclusion Taking metoprolol, Shenmai injection treatment on patients with chronic heart failure after the ef ect is very ideal, it should be carried out in the hospital.